Intestinal and systemic imune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

Vaccine

Volumn 14, Issue 15, 1996, Pages 1459-1465

  Jertborn, Marianne ^a   Svennerholm, Ann Mari ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibody secreting cells; Intestinal immunity; Oral cholera vaccine; V. cholerae O1; V. cholerae O139

Indexed keywords

CHOLERA VACCINE; BACTERIUM ANTIBODY; CHOLERA TOXIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIBRIO CHOLERAE; BLOOD; COMPARATIVE STUDY; GASTROINTESTINAL DISEASE; GENETICS; IMMUNOLOGY; INTESTINE; MIDDLE AGED;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, BACTERIAL; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; MALE; MIDDLE AGED; VIBRIO CHOLERAE;

EID: 0030299845     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00071-0     Document Type: Article

References (35)

1. 1 Institute of Medicine. New Vaccine Development, Establishing Priorities: Volume II. Diseases of Importance in Developing Countries, National Academy Press, Washington CD, 1986
2. 2 Clemens, J.D., Sack, D.A., Harris, J.R., Van Loon, F., Chakraborty, J., Ahmed, F. et al. Field trial of oral cholera vaccine in Bangladesh: results from three-year follow-up. Lancet 1990, 335, 270-273
3. 3 Holmgren, J., Jertborn, M., Svennerholm, A.-M., Sack, D.A. and Clemens, J.D. New and improved vaccines against cholera. I. The oral B subunit/inactivated whole cell vaccine. In: New Generation Vaccines (Eds Woodrow, G.C. and Levine, M.M). Marcel Dekker, New York, USA, 1990, pp. 289-304
4. 4 Holmgren, J., Svennerholm, A.-M., Jertborn, M., Clemens, J., Sack, D.A., Salenstedt, R. et al. An oral B subunit-whole cell vaccine against cholera. Vaccine 1992, 10, 911-914
5. 5 Jertborn, M., Svennerholm, A.-M. and Holmgren, J. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 1992, 10, 130-132
6. 6 Sanchez, J.L., Trofa, F.A., Taylor, D.N., Kuschner, R.A., DeFraites, R.F., Craig, S.C. et al. Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers. J. Infect. Dis. 1993, 167, 1446-1449
7. 7 Eastman, A.C., Giraldo, A., Castaneda, E., Martinez, M., de la Hoz, F., Rivas, F. et al. Safety and immunogenicity of oral whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Bull. Pan. Am. Health Organ. 1996 (in press).
8. 8 Sanchez, J.L., Vasquez, B., Begue, R.E., Meza, R., Castellares, G., Cabezas, C. et al. Protective efficacy of oral whole-cell/recombinant-β-subunit cholera vaccine in Peruvian military recruits. Lancet 1994, 344, 1273-1276
9. 9 Ramamurthy, T., Garg, S., Sharma, R., Bhattacharya, S.K., Balakrish Nair, G., Shimada, T. et al. Emergence of a novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993, 341, 703-704
10. 10 Balakrish Nair, G., Ramamurthy, T., Bhattacharya, S.K., Mukhopadhyay, A.K., Takeda, T., Shimada, T. et al. Spread of Vibrio cholerae O139 Bengal in India. J. Infect. Dis. 1994, 169, 1029-1034
11. 11 Cholera Working Group International Centre for Diarrhoeal Disease Research, Bangladesh. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 1993, 342, 387-390
12. 12 Chongsa-Nguan, M., Chaicumpa, W., Moolasart, P., Kandhasingha, P., Shimada, T., Kurazono, H. et al. Vibrio cholerae O139 Bengal in Bangkok. Lancet 1993, 342, 430-431
13. 13 Lebens, M. and Holmgren, J. Structure and arrangement of the cholera toxin genes in Vibrio cholerae O139. FEMS Microbiol. Lett. 1994, 117, 197-202
14. 14 Bik, E.M., Bunschoten, A.E., Gouw, R.D. and Mooi, F.R. Genesis of the novel epidemic Vibrio cholerae O139 strain; evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 1995, 14, 209-216
15. 15 Waldor, M.K., Colwell, R. and Mekalanos, J.J. The Vibrio cholerae O139 serogroup antigen includes and O-antigen capsule and lipopolysaccharide virulence determinant. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11388-11392
16. 16 Albert, M.J., Alam, J., Ansaruzzaman, J., Qadri, F. and Sack, R.B. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization with V. cholerae O1 vaccine strain CVD103-HgR. J. Infect. Dis. 1994, 169, 230-231
17. 17 Svennerholm, A.-M. and Holmgren, J. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect. Immun. 1976, 13, 735-740
18. 18 Clemens, J.D., Harris, J.R., Sack, D.A., Chakraborty, J., Ahmed, F., Stanton, B.F. et al. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. Lancet 1988, 158, 60-69
19. 19 Clemens, J.D., Sack, D.A., Harris, J.R., Chakraborty, J., Khan, M.R., Stanton, B.F. et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, ii, 124-127
20. 20 Jonson, G., Osek, J., Svennerholm, A.-M. and Holmgren, J. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development. Infect. Immun. 1996, in press.
21. 21 Holmgren, J., Svennerholm, A.-M., Jertborn, M., Jonson, G., Osek, J., Askelöf, P. and Wigzell, H. Development of a bivalent B subunit-O1/O139 whole cell cholera vaccine. Bull. WHO 1996, in press
22. 22 Sanchez, J. and Holmgren, J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 481-485
23. 23 Jertborn, M., Svennerholm, A.-M. and Holmgren, J. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 1993, 11, 1007-1012
24. 24 Svennerholm, A.-M., Jertborn, M., Gothefors, L., Karim, A.M.M.M., Sack, D.A. and Holmgren, J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 1984, 149, 884-893
25. 25 Åhrén, C., Wennerås, C., Holmgren, J. and Svennerholm, A.-M. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 1993, 11, 929-934
26. 26 Gaspari, M.M., Brennan, P.T., Solomon, S.M. and Elson, C.O. A method of obtaining, processing and analyzing human intestinal secretions for antibody content. J. Immunol. Methods 1988, 110, 85-91
27. 27 Svennerholm, A.-M., Holmgren, J., Black, R., Levine, M. and Merson, M. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 1983, 147, 514-522
28. 28 McIntyre, O.R. and Feeley, J.C. Passive serum protection of the infant rabbit against experimental cholera. J. Infect. Dis. 1964, 114, 468-475
29. 29 Jertborn, M., Svennerholm, A.-M. and Holmgren, J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 1986, 24, 203-209
30. 30 Czerkinsky, C., Nilsson, L.-Å., Nygren, H., Ouchterlony, Ö. and Tarkowski, A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983, 65, 109-121
31. 31 Quiding-Järbrink, M., Lakew, M., Nordström, I., Banchereau, J., Butcher, E., Holmgren, J. and Czerkinsky, C. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur. J. Immunol. 1996 (in press)
32. 32 Clemens, J.D., Stanton, B.F., Chakraborty, J., Sack, D.A., Khan, M.R., Huda, S. et al. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity. J. Infect. Dis. 1987, 155, 79-85
33. 33 Johnson, J.A., Salles, C.A., Panigraphi, P., Albert, M.J., Wright, A.C., Johnson, R.J. et al. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect. Immun. 1994, 62, 2108-2110
34. 34 Weintraub, A., Widmalm, G., Jansson, P.-E., Jansson, M., Hultenby, K. and Albert, M.J. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathogen. 1994, 16, 235-241
35. 35 Jertborn, M., Svennerholm, A.-M. and Holmgren, J. Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine. Int. Archs. Allergy. appl. Immun. 1984, 75, 38-43